Japan, Nov. 7 -- ASCENDIS PHARMA GROWTH DISORDERS A S has got intellectual property rights for 'CONTROLLED-RELEASE CNP AGONISTS WITH INCREASED NEP STABILITY.' Other related details are as follows:

Application Number: JP,2024-090343

Category (FI): A61K38/22,A61P43/00,123,A61K47/65,A61K47/60,A61P19/00,A61K45/00

Stage: Grant (IP right document published.)

Filing Date: June 4, 2024

Publication Date: Aug. 21, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....